Glucosylceramide-mediated feedback loop drives GBA-synuclein pathology

Mechanistic description

In GBA-associated PD, reduced glucocerebrosidase activity leads to glucosylceramide accumulation in neurons and glia, which directly promotes α-synuclein fibrillization by stabilizing toxic oligomers and disrupting membrane curvature. These α-synuclein aggregates subsequently traffic to the lysosome where they inhibit wild-type GBA activity and impair ER-Golgi trafficking of new GBA enzyme, creating a feedforward loop. I hypothesize that pharmacological restoration of GBA activity using allosteric activators (not chaperones) will preferentially reduce glucosylceramide levels, disrupting this loop and reducing α-synuclein seeding capacity in patient-derived neurons.

Mechanism / pathway

GBA1
→
Lysosomal glucosylceramide metabolism and α-synuclein aggregation
→
Parkinson's disease

Evidence for (5)

Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.

PMID:36598340 2023 Mov Disord
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.

PMID:39267121 2024 Transl Neurodegener
Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations.

PMID:34151863 2021 J Parkinsons Dis
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.

PMID:37195859 2023 Mov Disord
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1.

PMID:38924406 2024 Sci Adv

Evidence against (3)

Evidence matrix

5 supporting 0 contradicting

47% posterior support

Supporting

Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser. PMID:36598340 · 2023 · Mov Disord
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease. PMID:39267121 · 2024 · Transl Neurodegener
Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations. PMID:34151863 · 2021 · J Parkinsons Dis
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator. PMID:37195859 · 2023 · Mov Disord
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1. PMID:38924406 · 2024 · Sci Adv

Contradicting

No contradicting evidence recorded.

Bayesian persona consensus

47% posterior support

1 signal · 0 for / 1 against · agreement 0%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). Glucosylceramide-mediated feedback loop drives GBA-synuclein pathology. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-db6058d23e

BibTeX

@misc{scidex_hypothesis_hdb6058d,
  title        = {Glucosylceramide-mediated feedback loop drives GBA-synuclein pathology},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-db6058d23e},
  note         = {SciDEX artifact hypothesis:h-db6058d23e}
}